Antiinflammatory-antioxidant treatment methane sulfonanilide allergen-induced asthma groups asthmatic patients biphasic bronchospastic response Dermatophagoides allergen extract double-blind fashion Early late asthmatic reactions inhalation challenge end treatment period nimesulide sulfonanilide antioxidant properties placebo Bronchial responsiveness hours allergen inhalation challenges dose allergen EAR decrease severity LAR maximum fall similar end treatment period groups patients nimesulide bronchial responsiveness allergen inhalation end treatment period results hypothesis production oxygen-free radicals significant role development bronchial hyperresponsiveness late phase reaction asthma 